Ignite Creation Date:
2025-12-24 @ 11:49 PM
Ignite Modification Date:
2025-12-25 @ 9:44 PM
Study NCT ID:
NCT02203851
Status:
COMPLETED
Last Update Posted:
2019-11-08
First Post:
2014-07-29
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Extension Trial Assessing the Safety and Efficacy of BI 655066/ABBV-066/Risankizumab in Patients With Moderate to Severe Chronic Plaque Psoriasis
Sponsor:
AbbVie
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-11-20
Start Date Type:
ACTUAL
Primary Completion Date:
2018-09-04
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-09-04
Completion Date Type:
ACTUAL
First Submit Date:
2014-07-29
First Submit QC Date:
None
Study First Post Date:
2014-07-30
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2019-05-10
Results First Submit QC Date:
None
Results First Post Date:
2019-11-08
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-10-21
Last Update Post Date:
2019-11-08
Last Update Post Date Type:
ACTUAL